z-logo
Premium
Sustained and full fetal hemoglobin production after failure of bone marrow transplant in a patient homozygous for beta 0‐thalassemia: A clinical remission despite genetic disease and transplant rejection
Author(s) -
Paciaroni Katia,
Gallucci Cristiano,
De Angelis Gioia,
Alfieri Cecilia,
Roveda Andrea,
Lucarelli Guido
Publication year - 2009
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.21392
Subject(s) - medicine , thalassemia , bone marrow transplant , hemoglobinopathy , bone marrow , fetal hemoglobin , beta thalassemia , fetus , bone marrow transplantation , disease , gastroenterology , surgery , pregnancy , biology , genetics
An adult patient affected by β 0 ‐thalassemia major underwent allogeneic bone marrow transplant (BMT) from a matched related donor. Forty days after transplant, allogeneic engraftment failure and autologous β 0 ‐thalassemic bone marrow recovery were documented. Red blood cell transfusions were required until 118 days post‐transplant. Thereafter, the haemoglobin (Hb) levels stabilized over 11.8 gr/dl throughout the ongoing 34‐month follow‐up, abolishing the need for transfusion support. The Hb electrophoresis showed 100% Hb Fetal (HbF). This unexplained case suggests full HbF production may occur in an adult patient with β 0 ‐thalassemia major. Am. J. Hematol. 2009. © 2009 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom